Candel Therapeutics (CADL) Return on Assets [ROA] (2021 - 2026)
Candel Therapeutics (CADL) posted Return on Assets [ROA] of -39.37% for Q2 2026, down 4.46 percentage points from -34.91% a year earlier.
Powered by 
Analysis
Candel Therapeutics (CADL) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Candel Therapeutics' Return on Assets [ROA] came in at -40.05%, up 6.38 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a four-year change of +0.39 percentage points (FY2021 to FY2025).
- In prior years, Candel Therapeutics' Return on Assets [ROA] was -46.43% in FY2024 (+19.01 pp), -65.45% in FY2023 (-23.25 pp), -42.20% in FY2022 (-1.75 pp) and -40.44% in FY2021.
- Quarterly Return on Assets [ROA] has run from a low of -152.95% in Q3 2024 to a high of -27.84% in Q4 2021 over five years.
- On a year-over-year basis, Return on Assets [ROA] increased in five of the last seven quarters, with an average year-over-year change of +32.75 percentage points.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2025, with a gain of 114.22 percentage points; the weakest was Q3 2024, with a drop of 86.38 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 2.14% |
| 10 | Candel Therapeutics | 773.36 Mn | 773.36 Mn | - | -39.37% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -39.37% |
| Dec 31, 2025 | -42.48% |
| Sep 30, 2025 | -38.73% |
| Jun 30, 2025 | -34.91% |
| Mar 31, 2025 | -33.19% |
| Dec 31, 2024 | -53.55% |
| Sep 30, 2024 | -152.95% |
| Jun 30, 2024 | -127.31% |
| Mar 31, 2024 | -103.85% |
| Dec 31, 2023 | -85.26% |
| Sep 30, 2023 | -66.57% |
| Jun 30, 2023 | -57.54% |
| Mar 31, 2023 | -49.10% |
| Dec 31, 2022 | -43.28% |
| Sep 30, 2022 | -39.36% |
| Jun 30, 2022 | -34.97% |
| Mar 31, 2022 | -31.74% |
| Dec 31, 2021 | -27.84% |
| Sep 30, 2021 | -38.05% |
API Access
Candel Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CADL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CADL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CADL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();